Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting
1998

Microvessel Density and Prostate Cancer Survival

Sample size: 221 publication Evidence: high

Author Information

Author(s): M Borre, BV Offersen, B Nerstr0m, J Overgaard

Primary Institution: Danish Cancer Society, University Hospital of Aarhus

Hypothesis

Does microvessel density at diagnosis correlate with disease-specific survival in prostate cancer patients?

Conclusion

Microvessel density is a significant predictor of disease-specific survival in prostate cancer patients subjected to watchful waiting.

Supporting Evidence

  • Microvessel density was significantly associated with clinical stage and histopathological grade.
  • MVD was a significant predictor of disease-specific survival in both the entire population and the clinically localized subpopulation.
  • 98% of patients had died by the end of the follow-up period, with 57% dying from prostate cancer.

Takeaway

This study found that counting the tiny blood vessels in prostate tumors can help predict how long patients might live after diagnosis.

Methodology

Microvessel density was quantified in tumor samples from 221 prostate cancer patients using immunohistochemical methods.

Potential Biases

Potential biases due to retrospective data collection and the lack of standardized methods for measuring microvessel density.

Limitations

The study is retrospective and relies on previously collected data, which may introduce inaccuracies.

Participant Demographics

Median age of participants was 75 years, with a range from 49 to 95 years.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI 2.17-6.82

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication